Radioligand Therapy: Targeted Cancer Treatment | Health and Fitness News

Health News Today | 2 Min News | The Daily News Now! · Sep 9, 2026 · 2m

Radioligand therapy is a groundbreaking cancer treatment that delivers radiation directly to tumors using radioactive isotopes like lutetium-177, targeting specific receptors on cancer cells for precision strikes. Unlike traditional external beam radiation, this internal approach minimizes damage to healthy tissue. Approved in the U.S. as Pluvicto for metastatic prostate cancer, it involves six IV infusions spaced six weeks apart—quick, manageable, and similar to other intravenous treatments. After infusion, patients must follow strict safety protocols: drink plenty of fluids, avoid close…